181 related articles for article (PubMed ID: 37225974)
1. Software compatibility analysis for quantitative measures of [
Pemberton HG; Buckley C; Battle M; Bollack A; Patel V; Tomova P; Cooke D; Balhorn W; Hegedorn K; Lilja J; Brand C; Farrar G
EJNMMI Res; 2023 May; 13(1):48. PubMed ID: 37225974
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of semi-quantitative measures of
Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
[TBL] [Abstract][Full Text] [Related]
3. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
[TBL] [Abstract][Full Text] [Related]
4. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
5. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
[TBL] [Abstract][Full Text] [Related]
7. Is there a difference in regional read [
Farrar G; Molinuevo JL; Zanette M
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1299-1308. PubMed ID: 30863934
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Evaluation of
Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
Front Neurol; 2020; 11():578753. PubMed ID: 33519667
[No Abstract] [Full Text] [Related]
9. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
Schreiber S; Landau SM; Fero A; Schreiber F; Jagust WJ;
JAMA Neurol; 2015 Oct; 72(10):1183-90. PubMed ID: 26280102
[TBL] [Abstract][Full Text] [Related]
11. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [
Bucci M; Savitcheva I; Farrar G; Salvadó G; Collij L; Doré V; Gispert JD; Gunn R; Hanseeuw B; Hansson O; Shekari M; Lhommel R; Molinuevo JL; Rowe C; Sur C; Whittington A; Buckley C; Nordberg A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2183-2199. PubMed ID: 33844055
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
Leinonen V; Rinne JO; Wong DF; Wolk DA; Trojanowski JQ; Sherwin PF; Smith A; Heurling K; Su M; Grachev ID
Acta Neuropathol Commun; 2014 Apr; 2():46. PubMed ID: 24755237
[TBL] [Abstract][Full Text] [Related]
13. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
[TBL] [Abstract][Full Text] [Related]
14. Estimation of amyloid distribution by [
Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
[TBL] [Abstract][Full Text] [Related]
15. Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Miki T; Shimada H; Kim JS; Yamamoto Y; Sugino M; Kowa H; Heurling K; Zanette M; Sherwin PF; Senda M
Ann Nucl Med; 2017 Apr; 31(3):260-272. PubMed ID: 28181118
[TBL] [Abstract][Full Text] [Related]
16. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
Hatashita S; Yamasaki H; Suzuki Y; Tanaka K; Wakebe D; Hayakawa H
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of
Sur C; Adamczuk K; Scott D; Kost J; Sampat M; Buckley C; Farrar G; Newton B; Suhy J; Bennacef I; Egan MF
Mol Imaging Biol; 2022 Dec; 24(6):862-873. PubMed ID: 35794343
[TBL] [Abstract][Full Text] [Related]
18. Computed Tomography Density and β-Amyloid Deposition of Intraorbital Optic Nerve May Assist in Diagnosing Mild Cognitive Impairment and Alzheimer's Disease: A
Wu H; Lei Z; Ou Y; Shi X; Xu Q; Shi K; Ding J; Zhao Q; Wang X; Cai X; Liu X; Lou J; Liu X
Front Aging Neurosci; 2022; 14():836568. PubMed ID: 35370601
[TBL] [Abstract][Full Text] [Related]
19. Spatial Normalization of
Lilja J; Leuzy A; Chiotis K; Savitcheva I; Sörensen J; Nordberg A
J Nucl Med; 2019 Feb; 60(2):285-291. PubMed ID: 29903930
[TBL] [Abstract][Full Text] [Related]
20. Early-phase
Boccalini C; Peretti DE; Ribaldi F; Scheffler M; Stampacchia S; Tomczyk S; Rodriguez C; Montandon ML; Haller S; Giannakopoulos P; Frisoni GB; Perani D; Garibotto V
J Nucl Med; 2022 Jul; 64(2):266-73. PubMed ID: 35863896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
